Status:
COMPLETED
Preventing Propofol-associated Injection Pain
Lead Sponsor:
Benaroya Research Institute
Conditions:
Pain
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Injection of propofol is associated with discomfort in subsets of patients. Local anesthetics have been shown to attenuate this response in some patients. This randomized, double-blind, placebo-contro...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- weight \>40kg, \<100kg
- ambulatory surgery
- Exclusion criteria:
- allergy to propofol or lidocaine
- taking opioids, benzodiazepines, or nonsteroidal antiinflammatory drugs (NSAIDs)
Exclusion
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT00864682
Start Date
January 1 2008
End Date
April 1 2009
Last Update
January 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Benaroya Research Institute
Seattle, Washington, United States, 98101